PFE
stock Healthcare Drug Manufacturers - GeneralOverall Mixed · 42%
- Fundamentals Fair
- Trajectory Slipping
- Leadership Normal
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Mixed 1 of 5 trend signals bullishRSI 37 — soft momentum, not yet oversold.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $25.36
- -0.74%
- Close
- $25.36
- -0.74%
- Current
- $25.36
- Prev close
- $25.55
- Today
- 21.73M
- 3-mo avg
- 36.97M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- May 577 days ago
- Next expected
- Jul 29in 8 days
Recent earnings dates
- May 5 77 days ago
- Feb 3 168 days ago
- Nov 4, 2025 259 days ago
- Aug 5, 2025 350 days ago
Past earnings dates come from PFE’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 52d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), PFE’s fundamentals read as fair overall.
At 19.4x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 6.8% yield is high; it is worth checking the payout is covered by profit.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 12.4% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 9.0% return on equity is respectable, in the normal range.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 3.7% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 1.40, the company carries a moderate, manageable amount of debt.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 1.16, short-term assets cover short-term bills with a little room to spare.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue fell 1.6% from the prior year; the top line is contracting.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income fell 3.2% from the prior year; profit is shrinking.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 52d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $73.6B | $101.2B | $59.6B | $63.6B | $62.6B |
| Net income | $22.0B | $31.4B | $2.1B | $8.0B | $7.8B |
| Diluted EPS | $3.85 | $5.47 | $0.37 | $1.41 | $1.36 |
| Dividend / share | $1.57 | $1.61 | $1.65 | $1.69 | $1.72 |
| Total assets | $181.5B | $197.2B | $226.5B | $213.4B | $208.2B |
| Total liabilities | $104.0B | $101.3B | $137.2B | $124.9B | $121.4B |
| Shareholder equity | $77.5B | $95.9B | $89.3B | $88.2B | $86.5B |
| Q2-2024 | Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $13.3B | $17.7B | $17.8B | $13.7B | $14.7B | $16.7B | $17.6B | $14.5B |
| Net income | $41.0M | $4.5B | $410.0M | $3.0B | $2.9B | $3.5B | -$1.6B | $2.7B |
| Diluted EPS | $0.01 | $0.78 | $0.07 | $0.52 | $0.51 | $0.62 | $-0.29 | $0.47 |
| Dividend / share | $0.84 | $0.00 | $0.85 | $0.00 | $0.86 | $0.00 | $0.86 | $0.00 |
Leadershipsynced from SEC 59d ago
- Bourla Albert Chairman & CEO · Director
- Denton David M Chief Financial Officer & EVP
- Boshoff Christoffel President, R&D
- Damico Jennifer B. SVP & Controller
- Hancock Dennis P Executive Vice President
- Lankler Douglas M Executive Vice President
- Blaylock Ronald E Director
- Buckley Mortimer J Director
- Desmond-Hellmann Susan Director
- Echevarria Joseph Director
- Gottlieb Scott Director
- Littman Dan R. Director
- Narayen Shantanu Director
- Nora Johnson Suzanne M Director
- Quincey James Director
- Smith James C Director
- Taraporevala Cyrus Director
Officers and board are drawn from PFE’s recent SEC ownership filings (Forms 3, 4 and 5).
Recent leadership changes
Notable recent eventspast year
- Oct 1, 2025 +6.8% one-day move
- Sep 30, 2025 +6.8% one-day move
- Aug 5, 2025 +5.2% one-day move
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $1.72
- 2026 so far
- $0.862 payments
- 2026 projected
- $1.72+0.0% vs 2025
Projection scales PFE’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- May 8 $0.43
- Jan 23 $0.43
- Nov 7, 2025 $0.43
- Jul 25, 2025 $0.43
- May 9, 2025 $0.43
- Jan 24, 2025 $0.43
- Nov 8, 2024 $0.42
- Jul 26, 2024 $0.42
- May 9, 2024 $0.42
- Jan 25, 2024 $0.42
- Nov 9, 2023 $0.41
- Jul 27, 2023 $0.41
- May 11, 2023 $0.41
- Jan 26, 2023 $0.41
- Nov 3, 2022 $0.40
- Jul 28, 2022 $0.40
- May 12, 2022 $0.40
- Jan 27, 2022 $0.40
- Nov 4, 2021 $0.39
- Jul 29, 2021 $0.39
Recent SEC filingssynced from SEC 52d ago
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement